332 related articles for article (PubMed ID: 2791500)
1. Comparative in vitro activity of lomefloxacin, a difluoro-quinolone.
Robbins MJ; Baskerville AJ; Sanghrajka M; Mumtaz G; Felmingham D; Ridgway GL; Grüneberg RN
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):65S-76S. PubMed ID: 2791500
[TBL] [Abstract][Full Text] [Related]
2. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
McCarter YS; Mazens-Sullivan MF; Bartlett RC
Chemotherapy; 1992; 38(5):308-18. PubMed ID: 1337507
[TBL] [Abstract][Full Text] [Related]
3. Lomefloxacin, a new fluoroquinolone. Studies on in vitro antimicrobial spectrum, potency, and development of resistance.
Aldridge KE; Henderberg A; Gebbia K; Schiro DD; Janney A; Sanders CV
Diagn Microbiol Infect Dis; 1989; 12(3):221-33. PubMed ID: 2791485
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of lomefloxacin activity in Colombia.
Trujillo H; Mejia GI; Castrillon L; Gomez C
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):51S-52S. PubMed ID: 2791498
[TBL] [Abstract][Full Text] [Related]
5. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
Ismaeel NA; Tayeb OS
Microbios; 1993; 74(300):147-54. PubMed ID: 8396196
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of lomefloxacin against Chlamydia trachomatis, Neisseria gonorrhoeae, Haemophilus ducreyi, Mycoplasma hominis, and Ureaplasma urealyticum.
Hoban D; DeGagne P; Witwicki E
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):83S-86S. PubMed ID: 2507222
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo evaluations of A-80556, a new fluoroquinolone.
Clement JJ; Tanaka SK; Alder J; Vojtko C; Beyer J; Hensey D; Ramer N; McDaniel D; Chu DT
Antimicrob Agents Chemother; 1994 May; 38(5):1071-8. PubMed ID: 8067740
[TBL] [Abstract][Full Text] [Related]
8. Lomefloxacin, a new difluoroquinolone: in vitro activity against gram-positive and gram-negative bacteria.
Hoban D; Grabowski M; Koss J; Weselowski V
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):77S-82S. PubMed ID: 2791502
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro activity of lomefloxacin (SC 47111 or NY-198) against fresh clinical bacterial isolates.
Wright DN; Saxon B; Matsen JM
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):7S-11S. PubMed ID: 2791501
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of BAY 12-8039, a new fluoroquinolone.
Woodcock JM; Andrews JM; Boswell FJ; Brenwald NP; Wise R
Antimicrob Agents Chemother; 1997 Jan; 41(1):101-6. PubMed ID: 8980763
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of lomefloxacin (NY-198 or SC 47111).
Shah PM; Müller S; Kipp J; Stille W
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):97S-101S. PubMed ID: 2791506
[TBL] [Abstract][Full Text] [Related]
12. Lomefloxacin (SC 47111 or NY-198), a new difluorinated quinolone: comparison of the in vitro activity with other broad spectrum antimicrobials against Enterobacteriaceae, Acinetobacter spp, Aeromonas spp, and Pseudomonas aeruginosa.
Aldridge KE; Henderberg A; Sanders CV
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):1S-6S. PubMed ID: 2507219
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of lomefloxacin (SC 47111 or NY-198) against isolates of Legionella spp.
Dubois J; Joly JR
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):89S-91S. PubMed ID: 2791504
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone.
Nakamura S; Minami A; Nakata K; Kurobe N; Kouno K; Sakaguchi Y; Kashimoto S; Yoshida H; Kojima T; Ohue T
Antimicrob Agents Chemother; 1989 Aug; 33(8):1167-73. PubMed ID: 2802544
[TBL] [Abstract][Full Text] [Related]
15. A ten-laboratory study of lomefloxacin (NY-198 or SC 47111) antimicrobial activity in Argentina.
Bianchini HN; Sarachian B; Fernandez A; Paolasso R; Kaufman C; Notario R; Porven G; Ingaramo RA; Perez S; Ferrero SM
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):45S-50S. PubMed ID: 2676328
[TBL] [Abstract][Full Text] [Related]
16. In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections.
Hoogkamp-Korstanje JA
J Antimicrob Chemother; 1997 Sep; 40(3):427-31. PubMed ID: 9338498
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity of lomefloxacin (NY-198, SC 47111) against bacterial strains from Venezuela.
Torres JR
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):41S-43S. PubMed ID: 2791497
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial activity of DV-7751a, a new fluoroquinolone.
Tanaka M; Hoshino K; Ishida H; Sato K; Hayakawa I; Osada Y
Antimicrob Agents Chemother; 1993 Oct; 37(10):2112-8. PubMed ID: 8257132
[TBL] [Abstract][Full Text] [Related]
19. Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing.
Jones RN; Aldridge KE; Barry AL; Fuchs PC; Gerlach EH; Pfaller MA; Washington JA
Diagn Microbiol Infect Dis; 1988 Aug; 10(4):221-40. PubMed ID: 3072151
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of in vitro antimicrobial activity of lomefloxacin against staphylococci, enterococci, Enterobacteriaceae, and Pseudomonas aeruginosa.
Rossolini GM; Valentini S; Satta G
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):57S-64S. PubMed ID: 2507221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
